Arlington Dermatology
5301 Keystone Court
Rolling Meadows, Illinois 60008
Rolling Meadows, Illinois 60008
We've found
8 trials
at this facility
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
Updated: 12/31/1969
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Psoriasis Clinical Trial
Updated: 12/31/1969
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 12/31/1969
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials